In association with
Logo Logo Logo

‘Intervention on press, judiciary and human rights not acceptable’


LUMBINI: Former Prime Minister and Nepali Congress President Sher Bahadur Deuba has said that intervention on press, judiciary and human rights would not be acceptable to the NC.
At a press meet organised by Rupandehi chapter of Nepal Press Union at Bhairahawa airport on Sunday, NC President Deuba said, ‘The government has been making interference in all places. It has also been interfering on press freedom, independent judiciary and human rights commission. This move would not be acceptable at any cost.”
Protesting the government’s move, he said that the Commission for the Investigation of Abuse of Authority (CIAA) should carry out investigation on various issues including wide-body and Baluwatar land.
The NC President argued that the budget brought by the government has been arbitrarily distributed to its cadres.

For Indian tourists travelling by land:- 72 hours (-ve) C-19 report, CCMC form and Antigen Test at entry point

For Indian tourists travelling by land:- 72 hours (-ve) C-19 report, CCMC form and Antigen Test at entry point

Comment here !
Related News

KATHMANDU:- A meeting of the CPN (UML) Central Secretariat is being held at the party’s central office in Chyasal at

BIRGUNJ:- The meeting of the Central Working Committee of the Janata Samajwadi Party (JSP) Nepal is scheduled to be held

KATHMANDU:- Newly-appointed ministers of the CPN (Unified Socialist) are scheduled to take oath of office and secrecy on Monday. President

KATHMANDU:- President Bidya Devi Bhandari has reshuffled the Council of Ministers and work division as per the recommendation of Prime


Headlines
Information for Indian tourists travelling by land:- 72 hours (-) C-19 report, CCMC form and Antigen Test at entry point
Information for Indian tourists travelling by land:- 72 hours (-) C-19 report, CCMC form and Antigen Test at entry point
Information for Indian tourists travelling by land:- 72 hours (-) C-19 report, CCMC form and Antigen Test at entry point